←Back to Expert Scholars
Translational Medicine / 转化医学Checkpoint Combinations, Melanoma
Sapna Patel
MD
🏢University of Colorado Cancer Center🌐USA
Director, Melanoma and Skin Cancer Program
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Sapna Patel directs melanoma at the University of Colorado and led the landmark SWOG S1801 neoadjuvant pembrolizumab trial in resectable melanoma. She conducts studies of checkpoint combinations including in uveal melanoma. Her work has reshaped the role of perioperative immunotherapy.
Share:
🧪Research Fields 研究领域
neoadjuvant immunotherapy
SWOG S1801
melanoma
checkpoint combinations
uveal melanoma trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Sapna Patel 的研究动态
Follow Sapna Patel's research updates
留下邮箱，当我们发布与 Sapna Patel（University of Colorado Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment